June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Prevalence and Distribution of Venous Loops and Association with Retinal Ischemia in Diabetic Retinopathy Using Widefield Swept-Source Optical Coherence Tomography Angiography (WF SS-OCTA)
Author Affiliations & Notes
  • John Brown Miller
    Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
  • Rongrong Le
    Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
  • Ying Cui
    Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
  • Edward S Lu
    Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
  • Ying Zhu
    Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
  • Raviv Katz
    Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
  • Itika Garg
    Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
  • Jay Wang
    Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
  • Yifan Lu
    Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
  • Rebecca Zeng
    Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
  • Ines Lains
    Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
  • Dean Eliott
    Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
  • Deeba Husain
    Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
  • Joan W Miller
    Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
  • Leo A Kim
    Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
  • David M Wu
    Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   John Miller, Alcon (C), Allergan (C), Genentech (C), Sunovion (C), Zeiss (C); Rongrong Le, None; Ying Cui, None; Edward Lu, None; Ying Zhu, None; Raviv Katz, None; Itika Garg, None; Jay Wang, None; Yifan Lu, None; Rebecca Zeng, None; Ines Lains, None; Dean Eliott, None; Deeba Husain, Allergan (C), Commonwealth Grant (F), Genentech (C), Lions VisionGift (F), Macular Society (F), Omeicos Ophthalmics (C); Joan Miller, Drusolv Therapeutics (S), Genentech/Roch (C), Genentech/Roch (R), Heidelberg Engineering (C), Heidelberg Engineering (R), KalVista Pharmaceuticals (C), KalVista Pharmaceuticals (R), Lowy Medical Research Institute (F), ONL Therapeutics (C), ONL Therapeutics (P), ONL Therapeutics (R), Sunovion (C), Sunovion (R), Valeant Pharmaceuticals/Mass. Eye and Ear (P), Valeant Pharmaceuticals/Mass. Eye and Ear (R); Leo Kim, CureVac AG (F), National Eye Institute (F), Pykus Therapeutics (F); David Wu, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 1926. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      John Brown Miller, Rongrong Le, Ying Cui, Edward S Lu, Ying Zhu, Raviv Katz, Itika Garg, Jay Wang, Yifan Lu, Rebecca Zeng, Ines Lains, Dean Eliott, Deeba Husain, Joan W Miller, Leo A Kim, David M Wu; Prevalence and Distribution of Venous Loops and Association with Retinal Ischemia in Diabetic Retinopathy Using Widefield Swept-Source Optical Coherence Tomography Angiography (WF SS-OCTA). Invest. Ophthalmol. Vis. Sci. 2021;62(8):1926.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Retinal venous loops (RVLs) are rare findings in diabetic retinopathy (DR). Bek reported 7.7% prevalence of RVLs in patients with proliferative DR (PDR) using color fundus photography (CFP). However, previously reported prevalence of RVLs may be underestimated due to limited detection of vascular abnormalities on CFP. This study aimed to determine RVL prevalence, distribution and associated microvascular changes using WF SS-OCTA.

Methods : Retrospective, observational study including diabetic patients with proliferative DR (PDR), non-proliferative DR (NPDR) and no DR. All patients were imaged with WF SS-OCTA using Angio 6×6mm and Montage 15×15mm scan protocols centered on the fovea. Images were independently evaluated by two graders for the presence of RVLs and other DR lesions including nonperfusion areas (NPAs) and neovascularization (NV). RVLs were classified as type I or type II according to the branching level of the feeder vessel. Type I RVLs emerge from larger veins encompassing the first and second branching level from the central retinal vein; type II RVLs emerge from the third or higher branching level. A binary logistic regression model (outcome: presence of RVLs) was used for statistical analyses.

Results : One hundred and ninety-five eyes of 132 diabetic patients (n = 31 without DR; 57 NPDR and 107 PDR) were included. Among them, 22 eyes (11%) had RVLs on WF SS-OCTA. The prevalence of RVLs was higher in PDR eyes compared to NPDR eyes (18% vs. 5%, p<0.05, Chi-square test). Type II RVLs were more prevalent than type I RVLs (p<0.001, Chi-square test). In terms of distribution, RVLs were more likely to originate from superior (vs. inferior) and temporal (vs. nasal) veins (p<0.05, Chi-square test). More advanced severity of DR (OR = 4.495, 95% CI: 1.177-17.161, p = 0.028) and younger age (OR = 0.961, 95% CI: 0.926-0.998, p = 0.037) were associated with the presence of RVLs. NPAs and NV area/number were not significantly correlated with the presence of RVLs.

Conclusions : WF SS-OCTA is useful for the identification of RVLs in patients with DR. Severity of DR, but not ischemia-related imaging biomarkers, was associated with the presence of RVLs in our cohort. Further longitudinal studies may be needed to identify the role of RVLs in DR progression and retinal ischemia.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×